Greenwich LifeSciences, Inc. (GLSI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 126 transactions totaling $7.5M, demonstrating a bullish sentiment with $7.5M in net insider flow. The most recent transaction on Jan 13, 2026 involved a purchase of 1,800 shares valued at $53.7K.
No significant insider buying has been recorded for GLSI in the recent period.
No significant insider selling has been recorded for GLSI in the recent period.
Based on recent SEC filings, insider sentiment for GLSI is bullish with an Insider Alignment Score of 100/100 and a net flow of $7.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Greenwich LifeSciences, Inc. (GLSI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading GLSI stock, having executed 126 transactions in the past 90 days. The most active insider is Snehal Patel (Executive), who has made 80 transactions totaling $6.8M.
Get notified when executives and directors at GLSI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | Patel Snehal | Executive | Purchase | 1,800 | $29.83 | $53.7K | |
| Jan 12, 2026 | Patel Snehal | Executive | Purchase | 2,900 | $27.54 | $79.9K | |
| Dec 31, 2025 | Patel Snehal | Executive | Purchase | 4,300 | $21.36 | $91.8K | |
| Dec 18, 2025 | Patel Snehal | Executive | Purchase | 4,100 | $12.62 | $51.7K | |
| Nov 25, 2025 | Patel Snehal | Executive | Purchase | 4,600 | $8.37 | $38.5K | |
| Nov 7, 2025 | Patel Snehal | Executive | Purchase | 10,600 | $8.43 | $89.4K | |
| Oct 31, 2025 | Patel Snehal | Executive | Purchase | 2,300 | $9.26 | $21.3K | |
| Sep 26, 2024 | Patel Snehal | Executive | Purchase | 1,500 | $14.63 | $21.9K | |
| Aug 12, 2024 | Thompson Jaye | Executive | Purchase | 800 | $13.85 | $11.1K | |
| Aug 6, 2024 | Patel Snehal | Executive | Purchase | 2,000 | $13.81 | $27.6K | |
| Aug 5, 2024 | Patel Snehal | Executive | Purchase | 5,500 | $13.18 | $72.5K | |
| Aug 2, 2024 | Thompson Jaye | Executive | Purchase | 1,000 | $15.15 | $15.2K | |
| Jul 23, 2024 | Patel Snehal | Executive | Purchase | 1,500 | $15.89 | $23.8K | |
| Jul 18, 2024 | Thompson Jaye | Executive | Purchase | 1,000 | $16.00 | $16.0K | |
| Jun 13, 2024 | Patel Snehal | Executive | Purchase | 174,825 | $14.30 | $2.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 104 | $7.5M | 100.0% |
Other(J) | 3 | $0 | 0.0% |
Exercise(M) | 19 | $0 | 0.0% |
Insiders at Greenwich LifeSciences, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 126 transactions totaling $7.5M in purchases versus $0 in sales, the net buying activity of $7.5M signals strong executive confidence. Snehal Patel (Executive) leads the buying activity with $6.8M in transactions across all time.